IRON
Price:
$64.96
Market Cap:
$1.93B
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2020-08-12
Stock Exchange
NASDAQ
Ticker
IRON
According to Disc Medicine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.74B. This represents a change of 88.14% compared to the average of 926.03M of the last 4 quarters.
The mean historical Enterprise Value of Disc Medicine, Inc. over the last ten years is 320.90M. The current 1.74B Enterprise Value has changed 54.19% with respect to the historical average. Over the past ten years (40 quarters), IRON's Enterprise Value was at its highest in in the September 2024 quarter at 1.28B. The Enterprise Value was at its lowest in in the December 2022 quarter at -166863080.00.
Average
320.90M
Median
262.78M
Minimum
-172601543.90
Maximum
930.63M
Discovering the peaks and valleys of Disc Medicine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 930.63M
Minimum Annual Increase = -2632.29%
Minimum Annual Enterprise Value = -172601543.90
Year | Enterprise Value | Change |
---|---|---|
2023 | 930.63M | -639.18% |
2022 | -172601543.90 | -2632.29% |
2021 | 6.82M | -98.69% |
The current Enterprise Value of Disc Medicine, Inc. (IRON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
254.95M
5-year avg
320.90M
10-year avg
320.90M
Disc Medicine, Inc.’s Enterprise Value is greater than Anebulo Pharmaceuticals, Inc. (36.46M), greater than Adagene Inc. (22.22M), greater than Acrivon Therapeutics, Inc. Common Stock (163.47M), greater than AnaptysBio, Inc. (502.56M), greater than Mineralys Therapeutics, Inc. (523.81M), greater than Olema Pharmaceuticals, Inc. (468.89M), greater than Larimar Therapeutics, Inc. (363.34M), greater than Fennec Pharmaceuticals Inc. (105.60M), greater than Orchestra BioMed Holdings, Inc. (195.57M), greater than Biomea Fusion, Inc. (154.99M), less than Structure Therapeutics Inc. (1.75B), less than DICE Therapeutics, Inc. (1.82B), less than Morphic Holding, Inc. (2.81B), greater than Terns Pharmaceuticals, Inc. (222.97M), greater than Day One Biopharmaceuticals, Inc. (963.46M), greater than Acumen Pharmaceuticals, Inc. (139.19M), greater than Amylyx Pharmaceuticals, Inc. (291.98M), less than MoonLake Immunotherapeutics (3.05B), less than Crinetics Pharmaceuticals, Inc. (4.93B), less than Centessa Pharmaceuticals plc (1.75B), greater than Entrada Therapeutics, Inc. (686.76M),
Company | Enterprise Value | Market cap |
---|---|---|
36.46M | $37.86M | |
22.22M | $97.11M | |
163.47M | $202.87M | |
502.56M | $677.65M | |
523.81M | $621.09M | |
468.89M | $503.07M | |
363.34M | $393.05M | |
105.60M | $145.92M | |
195.57M | $219.34M | |
154.99M | $233.38M | |
1.75B | $1.91B | |
1.82B | $2.27B | |
2.81B | $2.86B | |
222.97M | $491.80M | |
963.46M | $1.38B | |
139.19M | $142.39M | |
291.98M | $361.25M | |
3.05B | $3.43B | |
4.93B | $5.20B | |
1.75B | $2.06B | |
686.76M | $703.50M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Disc Medicine, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Disc Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Disc Medicine, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Disc Medicine, Inc. (IRON)?
What is the 3-year average Enterprise Value for Disc Medicine, Inc. (IRON)?
What is the 5-year average Enterprise Value for Disc Medicine, Inc. (IRON)?
How does the current Enterprise Value for Disc Medicine, Inc. (IRON) compare to its historical average?